% | $
Quotes you view appear here for quick access.

Regulus Therapeutics Inc. Message Board

  • amgnjim amgnjim Jul 16, 2013 1:26 PM Flag

    Was this part of isis

    ISIS -------????

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Regulus was formed in September 2007 by Alnylam Pharmaceuticals (NASDAQ:ALNY) and Isis Pharmaceuticals (NASDAQ:ISIS). Regulus benefits substantially from the collective therapeutic RNA expertise of its founding companies, including established proprietary oligonucleotide-based technologies, and broad and dominant intellectual property estates specific to chemically modified oligonucleotides. Regulus has access to over 900 patents and patent applications pertaining to oligonucleotide technologies useful for targeting microRNA therapeutics, and over 170 patents and patent applications directed to microRNA specific technologies.

      Sentiment: Hold

3.570.00(+0.14%)Jul 29 4:00 PMEDT